Indian drug factories erode US generic prices

Downtrend: A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development centre in Mumbai, India. In August, the world’s largest copycat drugmaker, Israel’s Teva Pharmaceutical Industries Ltd, slashed its dividend; US giant Mylan NV lowered its profit target; and Sun Pharmaceutical reported its first quarterly loss in at least 12 years. — Reuters

Family-owned drugmakers driving price war

MUMBAI: The most recent earnings reports across the generic drug industry have read like dispatches from the front lines of a price war.